FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313327522> ?p ?o ?g. }

• W4313327522 endingPage "231" @default.
• W4313327522 startingPage "231" @default.
• W4313327522 abstract "(1) Background: We aimed to evaluate the risk of hepatitis B virus (HBV) reactivation in lung cancer patients treated with tyrosine kinase inhibitor (TKI), particularly in those with resolved HBV infection. (2) Methods: In this retrospective hospital-based cohort study, we screened all lung cancer patients with positive hepatitis B core antibodies (anti-HBc) receiving systemic antineoplastic treatment during the period from January 2011 to December 2020. Cumulative incidences of HBV reactivation, and their hazard ratios (HRs), were evaluated after adjusting patient mortality as a competing risk. (3) Results: Among 1960 anti-HBc-positive patients receiving systemic therapy, 366 were HBsAg-positive and 1594 were HBsAg-negative. In HBsAg-positive patients without prophylactic NUC, 3-year cumulative incidences of HBV reactivation were similar between patients receiving chemotherapy and patients receiving TKI (15.0%, 95% confidence interval (CI): 0−31.2% vs. 21.2%, 95% CI: 10.8−31.7%; p = 0.680). Likewise, 3-year cumulative incidences of HBV-related hepatitis were similar between the two groups (chemotherapy vs. TKI: 15.0%, 95% CI: 0−31.2% vs. 9.3%, 95% CI: 2.8−15.7%; p = 0.441). In 521 HBsAg-negative TKI users, the 3-year cumulative incidence of HBV reactivation was only 0.6% (95% CI: 0.0−1.9%). From multivariable regression analysis, we found that the only independent risk factor for HBV reactivation in TKI users was HBsAg positivity (HR 53.8, 95% CI: 7.0−412.9; p < 0.001). (4) Conclusion: Due to high risks of HBV reactivation in HBsAg-positive TKI users, NUC prophylaxis can be considered. However, in patients with resolved HBV infection, such risks are lower, and therefore regular monitoring is recommended." @default.
• W4313327522 created "2023-01-06" @default.
• W4313327522 creator A5033944706 @default.
• W4313327522 creator A5047628204 @default.
• W4313327522 creator A5048137173 @default.
• W4313327522 creator A5050554317 @default.
• W4313327522 creator A5051027323 @default.
• W4313327522 creator A5056070075 @default.
• W4313327522 creator A5073440860 @default.
• W4313327522 creator A5073941394 @default.
• W4313327522 creator A5075713583 @default.
• W4313327522 creator A5083103744 @default.
• W4313327522 date "2022-12-28" @default.
• W4313327522 modified "2023-10-18" @default.
• W4313327522 title "Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment" @default.
• W4313327522 cites W1964561800 @default.
• W4313327522 cites W2101159020 @default.
• W4313327522 cites W2156015715 @default.
• W4313327522 cites W2222056650 @default.
• W4313327522 cites W2547391316 @default.
• W4313327522 cites W2590941489 @default.
• W4313327522 cites W2612175225 @default.
• W4313327522 cites W2756557155 @default.
• W4313327522 cites W2791839818 @default.
• W4313327522 cites W2801666689 @default.
• W4313327522 cites W2910943640 @default.
• W4313327522 cites W2911749115 @default.
• W4313327522 cites W2943246216 @default.
• W4313327522 cites W2955639089 @default.
• W4313327522 cites W3012170433 @default.
• W4313327522 cites W3044418753 @default.
• W4313327522 cites W3141473743 @default.
• W4313327522 doi "https://doi.org/10.3390/jcm12010231" @default.
• W4313327522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36615034" @default.
• W4313327522 hasPublicationYear "2022" @default.
• W4313327522 type Work @default.
• W4313327522 citedByCount "2" @default.
• W4313327522 countsByYear W43133275222023 @default.
• W4313327522 crossrefType "journal-article" @default.
• W4313327522 hasAuthorship W4313327522A5033944706 @default.
• W4313327522 hasAuthorship W4313327522A5047628204 @default.
• W4313327522 hasAuthorship W4313327522A5048137173 @default.
• W4313327522 hasAuthorship W4313327522A5050554317 @default.
• W4313327522 hasAuthorship W4313327522A5051027323 @default.
• W4313327522 hasAuthorship W4313327522A5056070075 @default.
• W4313327522 hasAuthorship W4313327522A5073440860 @default.
• W4313327522 hasAuthorship W4313327522A5073941394 @default.
• W4313327522 hasAuthorship W4313327522A5075713583 @default.
• W4313327522 hasAuthorship W4313327522A5083103744 @default.
• W4313327522 hasBestOaLocation W43133275221 @default.
• W4313327522 hasConcept C120665830 @default.
• W4313327522 hasConcept C121332964 @default.
• W4313327522 hasConcept C126322002 @default.
• W4313327522 hasConcept C167135981 @default.
• W4313327522 hasConcept C203014093 @default.
• W4313327522 hasConcept C207103383 @default.
• W4313327522 hasConcept C2522874641 @default.
• W4313327522 hasConcept C2776256026 @default.
• W4313327522 hasConcept C2777382497 @default.
• W4313327522 hasConcept C2777410769 @default.
• W4313327522 hasConcept C2780593183 @default.
• W4313327522 hasConcept C44249647 @default.
• W4313327522 hasConcept C61511704 @default.
• W4313327522 hasConcept C71924100 @default.
• W4313327522 hasConcept C72563966 @default.
• W4313327522 hasConcept C88879693 @default.
• W4313327522 hasConcept C90924648 @default.
• W4313327522 hasConceptScore W4313327522C120665830 @default.
• W4313327522 hasConceptScore W4313327522C121332964 @default.
• W4313327522 hasConceptScore W4313327522C126322002 @default.
• W4313327522 hasConceptScore W4313327522C167135981 @default.
• W4313327522 hasConceptScore W4313327522C203014093 @default.
• W4313327522 hasConceptScore W4313327522C207103383 @default.
• W4313327522 hasConceptScore W4313327522C2522874641 @default.
• W4313327522 hasConceptScore W4313327522C2776256026 @default.
• W4313327522 hasConceptScore W4313327522C2777382497 @default.
• W4313327522 hasConceptScore W4313327522C2777410769 @default.
• W4313327522 hasConceptScore W4313327522C2780593183 @default.
• W4313327522 hasConceptScore W4313327522C44249647 @default.
• W4313327522 hasConceptScore W4313327522C61511704 @default.
• W4313327522 hasConceptScore W4313327522C71924100 @default.
• W4313327522 hasConceptScore W4313327522C72563966 @default.
• W4313327522 hasConceptScore W4313327522C88879693 @default.
• W4313327522 hasConceptScore W4313327522C90924648 @default.
• W4313327522 hasIssue "1" @default.
• W4313327522 hasLocation W43133275221 @default.
• W4313327522 hasLocation W43133275222 @default.
• W4313327522 hasLocation W43133275223 @default.
• W4313327522 hasOpenAccess W4313327522 @default.
• W4313327522 hasPrimaryLocation W43133275221 @default.
• W4313327522 hasRelatedWork W1554538335 @default.
• W4313327522 hasRelatedWork W2040973434 @default.
• W4313327522 hasRelatedWork W2123661325 @default.
• W4313327522 hasRelatedWork W2373048719 @default.
• W4313327522 hasRelatedWork W2556093218 @default.
• W4313327522 hasRelatedWork W2996529356 @default.
• W4313327522 hasRelatedWork W3163691534 @default.
• W4313327522 hasRelatedWork W4287377940 @default.

• next